CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation

Clinical trial NCT07662369 · RECRUITING

Trial details

NCT number: NCT07662369
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy Haplo-identical HCT

Start date: 2026-06-01
Primary completion: 2027-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.